Federal contract award
75A50223C00010
COVID-19 INJECTOR SETS CONTRACT TRANSITIONING FROM THE DOD/AF TO HHS/ASPR. DOD/AF CONTRACT NO.FA872620C0022.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | ASPR/DAAPPO/ORM HQ |
| NAICS | 339999 — All Other Miscellaneous Manufacturing |
| PSC | 6515 — Medical and Surgical Instruments, Equipment, and Supplies |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $19.3M |
| Current contract value | $19.3M |
| Potential contract value / ceiling | $19.3M |
| Start date | May 8, 2020 |
| Current end date | Jul 2, 2027 |
| Potential end date | Jul 2, 2027 |
| Latest award activity | Jan 5, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 9 of 9 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jan 5, 2026 | P00018 | $0 | THE PURPOSE OF THIS NO-COST MODIFICATION P00018 IS TO EXTEND THE PERIOD OF PERFORMANCE BY EIGHTEEN(18) MONTHS |
| Dec 18, 2025 | P00017 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO UPDATE THE CONTRACTING OFFICER'S REPRESENTATIVE (COR) FROM FRED KELLY TO JAISON EAPEN. |
| Mar 20, 2025 | P00016 | $0 | COVID-19 INJECTOR SETS CONTRACT TRANSITIONED FROM THE DOD/AF TO HHS/ASPR. DOD/AF CONTRACT NO.FA872620C0022. |
| Aug 29, 2024 | P00015 | $0 | COVID-19 INJECTOR SETS CONTRACT TRANSITIONED FROM THE DOD/AF TO HHS/ASPR. DOD/AF CONTRACT NO.FA872620C0022. |
| Oct 23, 2023 | P00014 | $0 | COVID-19 INJECTOR SETS CONTRACT TRANSITIONED FROM THE DOD/AF TO HHS/ASPR. DOD/AF CONTRACT NO.FA872620C0022. |
| Jun 7, 2023 | P00013 | $0 | COVID-19 INJECTOR SETS CONTRACT TRANSITIONED FROM THE DOD/AF TO HHS/ASPR. DOD/AF CONTRACT NO.FA872620C0022. |
| May 5, 2023 | P00012 | $0 | COVID-19 INJECTOR SETS CONTRACT TRANSITIONED FROM THE DOD/AF TO HHS/ASPR. DOD/AF CONTRACT NO.FA872620C0022. |
| Mar 24, 2023 | P00011 | $19.3M | COVID-19 INJECTOR SETS CONTRACT TRANSITIONED FROM THE DOD/AF TO HHS/ASPR. DOD/AF CONTRACT NO.FA872620C0022. |
| Mar 6, 2023 | 0 | $0 | COVID-19 INJECTOR SETS CONTRACT TRANSITIONING FROM THE DOD/AF TO HHS/ASPR. DOD/AF CONTRACT NO.FA872620C0022. |
Estimated positioning window
Nov 1, 2026 – Jan 30, 2027
55/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 55/100. Available recorded signals: 50 points.
- Contract end 2027-07-02 (243 days from calculation)
- +35 points
- 1 historical awards in this buyer and category group
- +0 points
- 9 recorded award transactions
- +10 points
- Latest award action: 2026-01-05
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.